Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Swiss drugmaker Novartis said on Friday it was looking into a report that employees of is Japanese unit may have violated clinical trial protocol by handling data from a small independent study of one of its cancer drugs.
Employees of Novartis Pharma K.K. (NPKK) transferred some data from research centers to a Tokyo hospital when that data should have been sent directly without first passing through Novartis hands, according to a report by Japanese broadcaster NHK that was picked up by the Wall Street Journal.
"NPKK is currently investigating the allegations," Novartis said in a statement.
http://www.reuters.com/article/2014/01/17/us-novartis-japan-idUSBREA0G1I520140117
Employees of Novartis Pharma K.K. (NPKK) transferred some data from research centers to a Tokyo hospital when that data should have been sent directly without first passing through Novartis hands, according to a report by Japanese broadcaster NHK that was picked up by the Wall Street Journal.
"NPKK is currently investigating the allegations," Novartis said in a statement.
http://www.reuters.com/article/2014/01/17/us-novartis-japan-idUSBREA0G1I520140117